22q1 all public funds accounted for 11.94%, with a month on month increase of + 0.83pp; The proportion of active medical fund was 17.8% month on month; Excluding index funds, the proportion was 7.95%, with a month on month increase of + 1.19pp; The market value of Shenwan pharmaceutical sector accounted for 8.55%, with a month on month increase of + 0.06pp.
From the number of public fund positions, the top five public funds are Wuxi Apptec Co.Ltd(603259) (848), Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) (534), Chongqing Zhifei Biological Products Co.Ltd(300122) (515), Asymchem Laboratories (Tianjin) Co.Ltd(002821) (238), and Hangzhou Tigermed Consulting Co.Ltd(300347) (200); In terms of changes, the top five stocks for the increase in the number of funds are: Chongqing Zhifei Biological Products Co.Ltd(300122) (+ 289), Wuxi Apptec Co.Ltd(603259) (+ 193), Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) (+ 99), Porton Pharma Solutions Ltd(300363) (+ 90), China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) (+ 73).
From the position proportion of public funds, 1) the top five positions in the proportion of circulating shares are: Porton Pharma Solutions Ltd(300363) (34.3%), Shanghai Medicilon Inc(688202) (24.2%), Beijing Sun-Novo Pharmaceutical Research Co.Ltd(688621) (23.3%), Asymchem Laboratories (Tianjin) Co.Ltd(002821) (22.2%), Wuxi Apptec Co.Ltd(603259) (21.6%); 2) The top five shares of total equity held are: Porton Pharma Solutions Ltd(300363) (29.1%), Wuxi Apptec Co.Ltd(603259) (21.5%), Asymchem Laboratories (Tianjin) Co.Ltd(002821) (21.3%), Zhejiang Jiuzhou Pharmaceutical Co.Ltd(603456) (17.7%), Hangzhou Tigermed Consulting Co.Ltd(300347) (15.5%).
In terms of the total market value of public fund positions, the top five positions are: Wuxi Apptec Co.Ltd(603259) (71.5 billion yuan), Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) (44.09 billion yuan), Chongqing Zhifei Biological Products Co.Ltd(300122) (26.34 billion yuan), Asymchem Laboratories (Tianjin) Co.Ltd(002821) (20.64 billion yuan), Aier Eye Hospital Group Co.Ltd(300015) (16.4 billion yuan); In terms of changes, the top five increases in the market value of fund positions are Chongqing Zhifei Biological Products Co.Ltd(300122) (+ 11.09 billion yuan), Wuxi Apptec Co.Ltd(603259) (+ 7.58 billion yuan), Beijing Tongrentang Co.Ltd(600085) (+ 2.83 billion yuan), China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) (+ 2.66 billion yuan), and Walvax Biotechnology Co.Ltd(300142) (+ 2.6 billion yuan).
Risk tip: the position analysis of public funds is based on the summary of the detailed holdings of heavy positions in 2022q1 quarterly report disclosed by open-end and closed-end public funds in the wind Fund database. There is a risk of sample error caused by the fact that some stocks are outside the top ten heavy positions.
